If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
88.00    1.90 (2.21%)
Bid:
88.90
Ask:
90.00
Spread: 1.10 (1.237%)
Market Cap: £144.27m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Director/PDMR Shareholding

3 Jan 2012 16:51

RNS Number : 9322U
Yule Catto & Co PLC
03 January 2012
 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

 

(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

 

(2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

 

(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

 

(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes in block capital letters. 

1. Name of the issuer

 

YULE CATTO & CO PLC

 

2. State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2R; (ii) a disclosure made in accordance with LR 9.8.6R(1); or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006)

 

(i)

 

3. Name of person discharging managerial responsibilities/director

 

DR ALEXANDER DOBBIE

 

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

 

NOTIFICATION RELATES TO DR A A DOBBIE AND HIS WIFE - MRS M S DOBBIE

 

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

 

NOTIICATION IS IN RESPECT OF THE BENEFICAL HOLDINGS OF DR DOBBIE AND HIS WIFE.

 

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

ORDINARY SHARES OF 10P EACH

 

7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

 

TD DIRECT INVESTING NOMINEES (EUROPE) LIMITED

 

8. State the nature of the transaction

 

SALE AND PURCHASE OF SHARES

 

9. Number of shares, debentures or financial instruments relating to shares acquired

 

16,000 SHARES

 

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

0.005%

 

11. Number of shares, debentures or financial instruments relating to shares disposed

 

16,000 SHARES

 

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

 

0.005%

 

13. Price per share or value of transaction

 

16,000 SHARES SOLD BY DR A A DOBBIE AT £1.6414 PER SHARE

3,000 SHARES BOUGHT BY DR A A DOBBIE AT £1.6487 PER SHARE

13,000 SHARES BOUGHT BY MRS M S DOBBIE AT £1.6546 PER SHARE

 

14. Date and place of transaction

 

31 DECEMBER 2011

 

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

 

TOTAL HOLDIG UNCHANGED AT 114,853 SHARES; 0.034% OF ISSUED SHARE CAPITAL

 

16. Date issuer informed of transaction

 

3 JANUARY 2012

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes 

17 Date of grant

 

 

18. Period during which or date on which it can be exercised

 

 

19. Total amount paid (if any) for grant of the option

 

 

20. Description of shares or debentures involved (class and number)

 

 

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

 

 

22. Total number of shares or debentures over which options held following notification

 

 

23. Any additional information

 

 

24. Name of contact and telephone number for queries

 

RICHARD ATKINSON

TEL: 01279 459512

 

Name and signature of duly authorised officer of issuer responsible for making notification

 

RICHARD ATKINSON - COMPANY SECRETARY

 

Date of notification

3 JANUARY 2012

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBKNDQABKDADK
Date   Source Headline
15th Dec 20212:54 pmRNSDirector/PDMR Shareholding
30th Nov 20214:57 pmRNSPUBLICATION OF CIRCULAR
26th Nov 20217:00 amRNSAppointment of Chief Financial Officer
22nd Nov 202110:36 amRNSDirector Declaration
11th Nov 20212:24 pmRNSDirector/PDMR Shareholding
4th Nov 20212:11 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSNew Chief Executive
28th Oct 20213:17 pmRNSResult of Placing
28th Oct 20217:00 amRNSAcquisition
28th Oct 20217:00 amRNSPROPOSED PLACING OF NEW ORDINARY SHARES
30th Sep 20213:08 pmRNSDirectorate Change
10th Sep 20218:23 amRNSDirector Declaration
5th Aug 20217:01 amRNSBoard Update
5th Aug 20217:00 amRNSInterim Results
20th Jul 202112:05 pmRNSSynthomer plc receives Green Economy Mark
19th Jul 20217:00 amRNSTrading Update
14th Jul 202111:02 amRNSDirector/PDMR Shareholding
9th Jul 20217:00 amRNSAppointment of Non-Executive Director
6th Jul 202112:37 pmRNSDirector/PDMR Shareholding
25th Jun 202110:01 amRNSFurther re Appointment of Group CEO
23rd Jun 20217:00 amRNSAppointment of Group Chief Executive Officer
18th May 20213:53 pmRNSDirector Declaration
12th May 20212:56 pmRNSDirector Declaration
6th May 20214:17 pmRNSDirector Declaration
6th May 20213:15 pmRNSDirector/PDMR Shareholding
29th Apr 20214:01 pmRNSResult of AGM
21st Apr 20217:00 amRNSQ1 Trading Update
31st Mar 20219:00 amRNSDirector/PDMR Shareholding
31st Mar 20219:00 amRNSDirector/PDMR Shareholding
30th Mar 202110:56 amRNSAnnual Financial Report
19th Mar 20212:38 pmRNSDirector/PDMR Shareholding
12th Mar 20213:17 pmRNSDirector/PDMR Shareholding
12th Mar 20213:16 pmRNSDirector/PDMR Shareholding
12th Mar 20213:14 pmRNSDirector/PDMR Shareholding
12th Mar 20213:14 pmRNSDirector/PDMR Shareholding
11th Mar 20219:43 amRNSHolding(s) in Company
4th Mar 202112:43 pmRNSPreliminary results – correction
4th Mar 20217:00 amRNSPreliminary Results year ended 31 December 2020
1st Mar 202112:58 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSStatement RE: Press Speculation
22nd Feb 20214:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20214:35 pmRNSPrice Monitoring Extension
19th Feb 20213:38 pmRNSHolding(s) in Company
14th Jan 20217:00 amRNSPre-Close Trading Update and Board Update
12th Jan 20219:36 amRNSHolding(s) in Company
6th Jan 20219:10 amRNSDirector Declaration
4th Jan 202110:09 amRNSDirector Declaration
23rd Dec 20204:54 pmRNSDirector/PDMR Shareholding
17th Dec 20207:00 amRNSAppointment of New Chair
18th Nov 20207:00 amRNSInvestor Seminar

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.